Currently, there is a wide variety of complex wounds: pressure, friction and moisture ulcers (resulting from dependency); lower extremity ulcers (venous, arterial and neuropathic, and diabetic foot ulcers); etc.
Pressure ulcers
Pressure ulcers (PU) are a frequent complication, especially in patients with reduced mobility and advanced age. It is estimated that they affect more than 90,000 people in Spain every day (1).
Diabetic foot
Diabetic foot, a complication of diabetes caused by vascular damage due to increased blood glucose, affects 19-34% of diabetics (2). 70% of these ulcers (DFU) remain open after 20 weeks of treatment (3).
INNOVATION IN WOUND PREVENTION AND TREATMENT PROCESSES
SABELEC® is specialized in the development of new medical devices for the prevention and treatment of wounds by electrostimulation.
GOAL
Our goal is to be a reference in improving the quality of life of people with reduced mobility and at risk of developing skin lesions through electrostimulation technologies.
VISION
Our clear vision is to develop innovative solutions that help healthcare professionals and improve people’s health and well-being.
SOLUTION: SABELEC WOUND HEALING
SABELEC WOUND HEALING is a device that delivers a treatment for chronic wounds by electrical stimulation. The device is easy to use for difficult-to-heal wounds, relieves pain and stimulates healing. It is a small, portable device that provides advanced therapy in a simple way that can be easily operated at home.
Domestic use
Easy to use
Relieves pain and stimulates healing
Small and portable device
Treatment for difficult-to-heal wounds
Electrostimulation is a technology approved by the European Wound Management Association (EWMA)
Safety and efficacy proven by clinical evidence (4) (5).
TECHNOLOGY
How does it work?
Electric fields are part of the fundamental mechanisms of cell and tissue growth and repair. SABELEC WOUND HEALING, through electrical stimulation, is able to simulate these electrical fields to aid in the repair process of the difficult-to-heal wound.
The benefits of electrical stimulation therapy have been demonstrated in numerous published clinical studies.
What is the treatment like?
SABELEC WOUND HEALING works by administering a preset, automated program of electrical pulses that automatically adjusts to the wound to ensure the optimal level of electrical stimulation. Stimulation levels are very low: below the level of sensitivity.
The estimated treatment period is two months. It starts with the simple application of two electrodes on the skin next to the wound. Daily treatments of between 6 and 19 hours should be applied, during the usual routine: watching TV, sleeping, walking, eating… This device is turned on and off with a simple button; in case of alert, the device notifies by lights and sound. You should follow up the wound in the usual way.
(1) Soldevilla, J. A., Torra, J. I. B., Posnett, J., Verdu, J. S., San, L. M., & Mayan, M. S. (2007). The Burden of Pressure Ulcers in Spain. Wounds: a compendium of clinical research and practice, 19(7), 201-206.
(2) Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017 Mar;49(2):106—16.
(3) Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA. Risk factors for delayed healing of neuropathic diabetic foot ulcers: a pooled analysis. Arch Dermatol. 2000 Dec;136(12):1531—5.
(4) Advanced Therapies in Wound Management. Piaggesi A, Läuchli S, Bassetto F et al. EWMA document: advanced therapies in wound management: cell and tissue based therapies, physical and bio-physical therapies smart and IT based technologies J Wound Care, 2018; 27(6), Suppl 6. JoWC_27_6_Supplemt-2_JWC-EWMA-supplement_advanced-therapies_Final3.pdf.
(5) J. Avendaño-Coy, P. López-Muñoz, D. Serrano-Muñoz, N. Comino-Suárez, C. Avendaño-López, y N. Martin-Espinosa, «Electrical microcurrent stimulation therapy for wound healing: A meta-analysis of randomized clinical trials», J.Tissue Viability, vol. 31, n.o 2, pp. 268-277, 2022, doi: https://doi.org/10.1016/j.jtv.2021.12.002.